Ascendis Pharma ordinary shares begin trading on Nasdaq, replacing ADS listing

• Ascendis Pharma began trading ordinary shares on Nasdaq Global Select Market on April 20, 2026, replacing its American Depositary Shares listing.
• Ordinary shares continue to trade under ticker ASND.
• Mandatory exchange of all outstanding ADSs into ordinary shares was completed on April 20, 2026, on a 1-for-1 basis.
• ADSs last traded on Nasdaq on April 17, 2026.
• Ordinary shares trade under CUSIP K08588103 and ISIN DK0060606333.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-162766), on April 20, 2026, and is solely responsible for the information contained therein.